METTL3 has been shown to promote m6A modification of histone transferase NDS2 mRNA in mice and promote the stability of NSD2 mRNA through YTHDF1, subsequently inhibiting renal fibrosis and renal injury in DN mice (Tang et al. 2022). This evidence concerns the gene METTL3 and liver dysplastic nodule.